MedCision ThawStar AT50
MedCision is the world leader in next-generation automated cell thawing for advanced therapies. The company develops and commercializes technologies that automate and standardize vital preclinical and clinical biologics handling for critical post-manufacturing processes. MedCision’s digitally enabled ThawSTAR Automated Cell Thawing Systems are designed to replace uncontrolled and highly variable manual methods, de-risking the therapeutic cell thawing process and optimizing cell efficacy. The ThawSTAR AT50 Thawing System is a first of it’s kind dry thawer that includes agitation and temperature monitoring. ThawSTAR Systems eliminate contamination by replacing unstandardized manual methods. Each ThawSTAR System can be leveraged early in R&D phase and scaled into commercial manufacturing and point of care.
- Industrial Design